PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
69.20
Similar ESG score to CGTX's 66.89. Bruce Berkowitz would investigate if industry ESG norms adequately address regulatory risks.
70.45
Environmental score 1.1-1.2x CGTX's 65.49. Guy Spier would verify if superior environmental practices translate to better regulatory positioning.
70.37
Social score 1.1-1.2x CGTX's 64.94. Guy Spier would verify if superior social practices translate to better employee engagement and customer satisfaction.
66.79
Similar governance score to CGTX's 70.23. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.